Is it time to redefine the role of low-dose radiotherapy for benign disease?

Montero A, Sabater S, Roedel F, Gaipl U, Ott O, Seegenschmiedt MH, Arenas M (2020)

Publication Type: Journal article, Letter

Publication year: 2020

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Book Volume: 79

Journal Issue: 3

DOI: 10.1136/annrheumdis-2018-214873

Authors with CRIS profile

Udo Gaipl Department of Radiation Oncology Oliver Ott Medizinische Fakultät

Involved external institutions

Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) Complejo Hospitalario Universitario de Albacete ES Spain (ES) Hospital Universitario HM Sanchinarro ES Spain (ES) Strahlenzentrum Hamburg MVZ DE Germany (DE) Universitat Rovira i Virgili (URV) ES Spain (ES)

How to cite

APA:

Montero, A., Sabater, S., Roedel, F., Gaipl, U., Ott, O., Seegenschmiedt, M.H., & Arenas, M. (2020). Is it time to redefine the role of low-dose radiotherapy for benign disease? Annals of the Rheumatic Diseases, 79(3). https://doi.org/10.1136/annrheumdis-2018-214873

MLA:

Montero, Angel, et al. "Is it time to redefine the role of low-dose radiotherapy for benign disease?" Annals of the Rheumatic Diseases 79.3 (2020).

BibTeX: Download